312 related articles for article (PubMed ID: 25391905)
1. Tyrosine phosphorylation of LRP6 by Src and Fer inhibits Wnt/β-catenin signalling.
Chen Q; Su Y; Wesslowski J; Hagemann AI; Ramialison M; Wittbrodt J; Scholpp S; Davidson G
EMBO Rep; 2014 Dec; 15(12):1254-67. PubMed ID: 25391905
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine-based signal mediates LRP6 receptor endocytosis and desensitization of Wnt/β-catenin pathway signaling.
Liu CC; Kanekiyo T; Roth B; Bu G
J Biol Chem; 2014 Oct; 289(40):27562-70. PubMed ID: 25143377
[TBL] [Abstract][Full Text] [Related]
3. G Protein-coupled receptor kinases phosphorylate LRP6 in the Wnt pathway.
Chen M; Philipp M; Wang J; Premont RT; Garrison TR; Caron MG; Lefkowitz RJ; Chen W
J Biol Chem; 2009 Dec; 284(50):35040-8. PubMed ID: 19801552
[TBL] [Abstract][Full Text] [Related]
4. Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction.
Davidson G; Wu W; Shen J; Bilic J; Fenger U; Stannek P; Glinka A; Niehrs C
Nature; 2005 Dec; 438(7069):867-72. PubMed ID: 16341016
[TBL] [Abstract][Full Text] [Related]
5. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
6. Amer1/WTX couples Wnt-induced formation of PtdIns(4,5)P2 to LRP6 phosphorylation.
Tanneberger K; Pfister AS; Brauburger K; Schneikert J; Hadjihannas MV; Kriz V; Schulte G; Bryja V; Behrens J
EMBO J; 2011 Apr; 30(8):1433-43. PubMed ID: 21304492
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6.
Wu G; Huang H; Garcia Abreu J; He X
PLoS One; 2009; 4(3):e4926. PubMed ID: 19293931
[TBL] [Abstract][Full Text] [Related]
8. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
[TBL] [Abstract][Full Text] [Related]
9. Receptor tyrosine kinases activate canonical WNT/β-catenin signaling via MAP kinase/LRP6 pathway and direct β-catenin phosphorylation.
Krejci P; Aklian A; Kaucka M; Sevcikova E; Prochazkova J; Masek JK; Mikolka P; Pospisilova T; Spoustova T; Weis M; Paznekas WA; Wolf JH; Gutkind JS; Wilcox WR; Kozubik A; Jabs EW; Bryja V; Salazar L; Vesela I; Balek L
PLoS One; 2012; 7(4):e35826. PubMed ID: 22558232
[TBL] [Abstract][Full Text] [Related]
10. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation.
Zeng X; Tamai K; Doble B; Li S; Huang H; Habas R; Okamura H; Woodgett J; He X
Nature; 2005 Dec; 438(7069):873-7. PubMed ID: 16341017
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and β-catenin signaling.
Reinke L; Lam AP; Flozak AS; Varga J; Gottardi CJ
Biochem Biophys Res Commun; 2016 Feb; 470(3):606-612. PubMed ID: 26797284
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of GSK3 by Wnt signalling--two contrasting models.
Metcalfe C; Bienz M
J Cell Sci; 2011 Nov; 124(Pt 21):3537-44. PubMed ID: 22083140
[TBL] [Abstract][Full Text] [Related]
13. Role of the Rap2/TNIK kinase pathway in regulation of LRP6 stability for Wnt signaling.
Park DS; Seo JH; Hong M; Choi SC
Biochem Biophys Res Commun; 2013 Jun; 436(2):338-43. PubMed ID: 23743195
[TBL] [Abstract][Full Text] [Related]
14. Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6.
MacDonald BT; Semenov MV; Huang H; He X
PLoS One; 2011; 6(8):e23537. PubMed ID: 21887268
[TBL] [Abstract][Full Text] [Related]
15. Direct inhibition of GSK3beta by the phosphorylated cytoplasmic domain of LRP6 in Wnt/beta-catenin signaling.
Piao S; Lee SH; Kim H; Yum S; Stamos JL; Xu Y; Lee SJ; Lee J; Oh S; Han JK; Park BJ; Weis WI; Ha NC
PLoS One; 2008; 3(12):e4046. PubMed ID: 19107203
[TBL] [Abstract][Full Text] [Related]
16.
Xu R; Wang X; Safi S; Braunegger N; Hipgrave Ederveen A; Rottmann M; Wittbrodt J; Wuhrer M; Wesslowski J; Davidson G
Cells; 2023 Mar; 12(6):. PubMed ID: 36980204
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein receptor-related protein 6 is a novel coreceptor of protease-activated receptor-2 in the dynamics of cancer-associated β-catenin stabilization.
Nag JK; Kancharla A; Maoz M; Turm H; Agranovich D; Gupta CL; Uziely B; Bar-Shavit R
Oncotarget; 2017 Jun; 8(24):38650-38667. PubMed ID: 28418856
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
19. Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of beta-catenin signaling.
Yamamoto H; Sakane H; Yamamoto H; Michiue T; Kikuchi A
Dev Cell; 2008 Jul; 15(1):37-48. PubMed ID: 18606139
[TBL] [Abstract][Full Text] [Related]
20. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
Peröbner I; Karow M; Jochum M; Neth P
Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
